Developing a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research

Pediatr Rheumatol Online J. 2014 Jul 21:12:31. doi: 10.1186/1546-0096-12-31. eCollection 2014.

Abstract

Background: Juvenile dermatomyositis (JDM) is a rare but severe autoimmune inflammatory myositis of childhood. International collaboration is essential in order to undertake clinical trials, understand the disease and improve long-term outcome. The aim of this study was to propose from existing collaborative initiatives a preliminary minimal dataset for JDM. This will form the basis of the future development of an international consensus-approved minimum core dataset to be used both in clinical care and inform research, allowing integration of data between centres.

Methods: A working group of internationally-representative JDM experts was formed to develop a provisional minimal dataset. Clinical and laboratory variables contained within current national and international collaborative databases of patients with idiopathic inflammatory myopathies were scrutinised. Judgements were informed by published literature and a more detailed analysis of the Juvenile Dermatomyositis Cohort Biomarker Study and Repository, UK and Ireland.

Results: A provisional minimal JDM dataset has been produced, with an associated glossary of definitions. The provisional minimal dataset will request information at time of patient diagnosis and during on-going prospective follow up. At time of patient diagnosis, information will be requested on patient demographics, diagnostic criteria and treatments given prior to diagnosis. During on-going prospective follow-up, variables will include the presence of active muscle or skin disease, major organ involvement or constitutional symptoms, investigations, treatment, physician global assessments and patient reported outcome measures.

Conclusions: An internationally agreed minimal dataset has the potential to significantly enhance collaboration, allow effective communication between groups, provide a minimal standard of care and enable analysis of the largest possible number of JDM patients to provide a greater understanding of this disease. This preliminary dataset can now be developed into a consensus-approved minimum core dataset and tested in a wider setting with the aim of achieving international agreement.

Keywords: Collaboration; Core set; Dataset; Disease activity; Idiopathic Inflammatory myopathy; International; Juvenile dermatomyositis.

Publication types

  • Dataset
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • Canada
  • Child
  • Dermatomyositis* / classification
  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / physiopathology
  • Dermatomyositis* / therapy
  • Disease Management*
  • Disease Progression
  • Female
  • Humans
  • International Cooperation
  • Ireland
  • Italy
  • Male
  • Outcome Assessment, Health Care
  • Patient Acuity
  • United Kingdom

Substances

  • Biomarkers

Supplementary concepts

  • Amyopathic dermatomyositis